RXR activating molecules

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7265139
APP PUB NO 20030105333A1
SERIAL NO

10098184

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to molecules having Formula (100): ##STR00001## wherein ---------- represents a bond present or absent; Ar is a substituted or unsubstituted benzene or pyridine ring; V is a C or N atom, and W, X, Y and Z together form a 2,4-thiazolidinedione, 2-thioxo-4-thiazolidinedione, isoxazolidinedione, 2,4-imidazolidinedione, [1,2,4]-oxadiazolidine-3,5-dione or 2-thioxo-4-imidazolidinedione residue; or a pharmaceutically acceptable salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MAXIA PHARMACEUTICALS INC10835 ALTMAN ROW SUITE 250 SAN DIEGO CA 92121

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jakubowicz-Jaillardon, Karine San Diego, CA 6 20
Tachdjian, Catherine San Diego, CA 76 1877

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation